Neighbourly Pharmacy Inc.
TSX:NBLY.TO
18.6 (CAD) • At close March 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Revenue
| 749.149 | 427.509 | 306.494 | 186.627 | 150.126 | 92.639 |
| Cost of Revenue
| 456.42 | 269.037 | 191.778 | 114.334 | 87.315 | 52.991 |
| Gross Profit
| 292.729 | 158.472 | 114.716 | 72.293 | 62.811 | 39.648 |
| Gross Profit Ratio
| 0.391 | 0.371 | 0.374 | 0.387 | 0.418 | 0.428 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 218.385 | 117.364 | 79.82 | 51.273 | 48.392 | 27.545 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 218.385 | 117.364 | 79.82 | 51.273 | 48.392 | 27.545 |
| Other Expenses
| 0.448 | -67.228 | -80.405 | -13.578 | -9.22 | -5.34 |
| Operating Expenses
| 278.222 | 142.718 | 98.938 | 65.054 | 61.166 | 34.598 |
| Operating Income
| -5.104 | -11.207 | 8.483 | 3.116 | -4.067 | -8.522 |
| Operating Income Ratio
| -0.007 | -0.026 | 0.028 | 0.017 | -0.027 | -0.092 |
| Total Other Income Expenses Net
| -10.46 | -83.833 | -87.7 | -17.701 | -14.932 | -18.912 |
| Income Before Tax
| -19.362 | -78.439 | -87.926 | -22.922 | -24.04 | -21.051 |
| Income Before Tax Ratio
| -0.026 | -0.183 | -0.287 | -0.123 | -0.16 | -0.227 |
| Income Tax Expense
| -4.563 | -6.044 | 2.591 | 0.422 | -1.281 | -3.01 |
| Net Income
| -15.499 | -73.356 | -91.332 | -23.344 | -22.759 | -18.041 |
| Net Income Ratio
| -0.021 | -0.172 | -0.298 | -0.125 | -0.152 | -0.195 |
| EPS
| -0.37 | -2.57 | -2.73 | -0.7 | -0.68 | -0.54 |
| EPS Diluted
| -0.37 | -2.57 | -2.73 | -0.7 | -0.68 | -0.54 |
| EBITDA
| 81.251 | -26.091 | -45.478 | 7.506 | 5.213 | 6.769 |
| EBITDA Ratio
| 0.108 | -0.061 | -0.148 | 0.04 | 0.035 | 0.073 |